Live
- Delhi's air quality may slip to 'severe' in 24 hours
- Speed up PAC-5 works, TTD Addl EO tells staff
- Shinde resigns as CM amid BJP's push for Fadnavis
- Supreme Court's no to ballots papers
- Isro's Shukrayaan gets Centre’s nod
- Nellore dist witnesses widespread rains
- POCSO case registered against ex-MLA Chevireddy
- Fight to save democracy, Constitution will continue: Kejriwal
- CM briefs Kharge on missive to Adani
- Contribute to achieve equality in society, people urged
Cyient inks pact with Agappe
Cyient inks pact with Agappe
IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine Count X to market.Mispa Count X is an indigenously designed and developed three-part haematologyanalyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
Hyderabad: IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine to market.Mispa Count X is an indigenously designed and developed three-part haematology analyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
As per the agreement, Cyient will manufacture certain key components of Mispa Count X at its ISO 13485-certified, state-of-art manufacturing facilities in India.
In a regulatory filing, Cyient DLM senior V-P and CEO Rajendra Velagapudi said: "We are proud to support the vision of an Atmanirbhar Bharat (self-reliant India) in the healthcare sector.
It is a matter of immense pride that with Agappe's new haematology product, even rural India and other remote locations of the country will have access to the best of diagnostic capabilities."
